Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

Hatem Soliman(Moffitt Cancer Center), Deanna Hogue(Moffitt Cancer Center), Hyo S. Han(Moffitt Cancer Center), Blaise Mooney(Moffitt Cancer Center), Ricardo Costa(Moffitt Cancer Center), Marie Catherine Lee(Moffitt Cancer Center), Bethany L. Niell(Moffitt Cancer Center), Angela Williams(Moffitt Cancer Center), Alec Chau(Moffitt Cancer Center), Shannon Falcon(Moffitt Cancer Center), Aixa Soyano(Moffitt Cancer Center), Avan Armaghani(Moffitt Cancer Center), Nazanin Khakpour(Moffitt Cancer Center), R. Jared Weinfurtner(Moffitt Cancer Center), Susan Hoover(Moffitt Cancer Center), John V. Kiluk(Moffitt Cancer Center), Christine Laronga(Moffitt Cancer Center), Marilin Rosa(Moffitt Cancer Center), Hung T. Khong(Moffitt Cancer Center), Brian J. Czerniecki(Moffitt Cancer Center)
Nature Medicine
March 17, 2023
10.1038/s41591-023-02309-4
Cited by 53Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis